Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Oncol Rep ; 42(5): 1981-1995, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31545451

ABSTRACT

Lung cancer is the leading cause of cancer mortality worldwide. Approximately 85% of all lung cancer cases are classified as non­small cell lung cancer (NSCLC). Currently, there is no standard method to predict the survival of patients with NSCLC. Insulin­like growth factor­binding proteins (IGFBPs) function as modulators of IGF signaling and are attracting increasing attention for their role in NSCLC. However, the prognostic values of individual IGFBPs in NSCLC, particularly at the mRNA level, remain unknown. In the present study, the distinct expression patterns and prognostic values of IGFBP family members in patients with NSCLC through bioinformatics analysis were reported using a series of databases, including Gene Expression Profiling Interactive Analysis, Kaplan­Meier Plotter, cBioPortal, GeneMANIA, and the Database for Annotation, Visualization and Integrated Discovery. In patients with NSCLC, IGFBP2 and IGFBP3 were significantly upregulated, while IGFBP6 was downregulated. High IGFBP1/2/4 expression was correlated with poor overall survival (OS) in all NSCLC types, especially adenocarcinoma; however, high IGFBP2/5 expression was significantly correlated with favorable OS only in patients with squamous cell carcinoma. In addition, aberrant IGFBP1/2/3/4/5 mRNA levels were associated with the prognosis of subsets of NSCLC with different clinicopathological features. These results indicated that various IGFBPs can serve as useful prognostic biomarkers and as potential targets for NSCLC therapies.


Subject(s)
Carcinoma, Non-Small-Cell Lung/genetics , Gene Expression Profiling/methods , Insulin-Like Growth Factor Binding Proteins/genetics , Lung Neoplasms/genetics , Biomarkers, Tumor/genetics , Carcinoma, Non-Small-Cell Lung/mortality , Data Mining , Female , Gene Expression Regulation, Neoplastic , Humans , Lung Neoplasms/mortality , Male , Prognosis , Survival Analysis
2.
Neuropsychologia ; 47(13): 2900-8, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19555702

ABSTRACT

The sex disparity in the development of depression has long been an important research topic, but the sex-related differences in neural activity during emotion regulation have been less thoroughly studied. It was hypothesized that, during the regulation of emotion, there would be more activation in the prefrontal regions implicated in cognitive processing for males, while there would be more activation in the prefrontal regions implicated in affective processing for females. This fMRI study recruited 12 females and 12 males who were required to view or to regulate the negative and positive emotion induced by some emotion-arousing pictures. During the regulation of negative emotion, both males and females had stronger activation in the left anterior cingulate gyrus, but males showed more activation in the prefrontal regions in general, including the left dorsolateral and lateral orbitofrontal gyrus as well as the right anterior cingulate gyrus, while females only showed stronger activation in the left medial orbitofrontal gyrus. For the regulation of positive emotion, both males and females showed stronger activation in the left dorsomedial prefrontal gyrus, but males were found to also have stronger activity in the left lateral orbitofrontal gyrus. It was concluded that there are common as well as sex-specific sets of brain regions involved in regulating negative and positive emotion, and the findings may have significant implications for females' vulnerability to developing depression.


Subject(s)
Emotions/physiology , Limbic System/physiology , Prefrontal Cortex/physiology , Sex Characteristics , Adult , Female , Humans , Magnetic Resonance Imaging , Male , Psychomotor Performance/physiology
3.
Neurosci Lett ; 457(2): 101-6, 2009 Jun 26.
Article in English | MEDLINE | ID: mdl-19429172

ABSTRACT

Regulation of emotion is important for adaptive social functioning and mental well-being. This functional magnetic resonance imaging study identified neural correlates of regulation of positive or negative emotion. Twelve healthy female Chinese participants performed the experimental task that required them to simply view emotional pictures or to regulate their emotions induced by these pictures while their brain activities were monitored by a 1.5 T MRI scanner. The neuroimaging findings indicate that the left superior and lateral frontal regions (BA8/9) are common neural correlates of regulation of both emotions. For regulation of positive or negative emotion, changes of BOLD responses in the prefrontal regions and the left insula are associated with regulation of positive emotion; whereas activity of the left orbitofrontal gyrus, the left superior frontal gyrus, and the anterior cingulate gyrus appears to be involved in regulation of negative emotion. According to the participants' self-report, they appeared to be more effective in regulating positive than negative emotions, which may relate to the distinct patterns of neural activity associated with regulation of the specific emotion. As a conclusion, our findings suggest that there are shared as well as valence-specific neurocognitive mechanisms underlying regulation of positive and negative emotions. Enhanced knowledge about the neural mechanisms of emotion regulation helps improve understanding of the complex interplay of emotion and cognition underlying human behaviors.


Subject(s)
Brain Mapping , Brain/physiology , Emotions/physiology , Adult , Female , Humans , Magnetic Resonance Imaging , Photic Stimulation
4.
BMC Cancer ; 8: 186, 2008 Jun 30.
Article in English | MEDLINE | ID: mdl-18590539

ABSTRACT

BACKGROUND: The aim of this study is to investigate the relationship between 16-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF (vascular endothelial growth factor) expression in patients with benign and malignant pulmonary nodules, and differential diagnosis between benign and malignant pulmonary nodules. METHODS: Sixty-four patients with benign and malignant pulmonary nodules underwent 16-slice spiral CT perfusion imaging. The CT perfusion imaging was analyzed for TDC (time density curve), perfusion parametric maps, and the respective perfusion parameters. Immunohistochemical findings of MVD (microvessel density) measurement and VEGF expression was evaluated. RESULTS: The shape of the TDC of peripheral lung cancer was similar to those of inflammatory nodule. PH (peak height), PHpm/PHa (peak height ratio of pulmonary nodule to aorta), BF (blood flow), BV (blood volume) value of peripheral lung cancer and inflammatory nodule were not statistically significant (all P > 0.05). Both showed significantly higher PH, PHpm/PHa, BF, BV value than those of benign nodule (all P < 0.05). Peripheral lung cancer showed significantly higher PS (permeability surface) value than that of inflammatory nodule and benign nodule (all P < 0.05). BV, BF, PS, MTT, PH, PHpm/PHa, and MVD among three groups of peripheral lung cancers were not significantly (all P > 0.05). In the case of adenocarcinoma, BV, BF, PS, PHpm/PHa, and MVD between poorly and well differentiation and between poorly and moderately differentiation were statistically significant (all P < 0.05). The peripheral lung cancers with VEGF positive expression showed significantly higher PH, PHpm/PHa, BF, BV, PS, and MVD value than those of the peripheral lung cancer with VEGF negative expression, and than those of benign nodule with VEGF positive expression (all P < 0.05). When investigating VEGF negative expression, it is found that PH, PHpm/PHa, and MVD of inflammatory nodule were significantly higher than those of peripheral lung cancer, PS of inflammatory nodule were significantly lower than that of peripheral lung cancer (all P < 0.05). PH, PHpm/PHa, BF, and BV of benign nodule were significantly lower than those of inflammatory nodule (all P < 0.05), rather than PS and MTT (mean transit time) (all P > 0.05). PH, PHpm/PHa, BV, and PS of benign nodule were significantly lower than those of peripheral lung cancer (all P < 0.05). In the case of VEGF positive expression, MVD was positively correlated with PH, PHpm/PHa, BF, BV, and PS of peripheral lung cancer and PS of benign nodule (all P < 0.05). CONCLUSION: Multi-slice spiral CT perfusion imaging closely correlated with tumor angiogenesis and reflected MVD measurement and VEGF expression. It provided not only a non-invasive method of quantitative assessment for blood flow patterns of peripheral pulmonary nodules but also an applicable diagnostic method for peripheral pulmonary nodules.


Subject(s)
Lung Neoplasms/blood supply , Neovascularization, Pathologic , Solitary Pulmonary Nodule/blood supply , Tomography, Spiral Computed , Vascular Endothelial Growth Factor A/biosynthesis , Adult , Aged , Cell Transformation, Neoplastic , Diagnosis, Differential , Female , Humans , Lung/blood supply , Lung/pathology , Lung Diseases/blood , Lung Diseases/diagnosis , Lung Diseases/pathology , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/pathology , Male , Middle Aged , Solitary Pulmonary Nodule/diagnostic imaging , Solitary Pulmonary Nodule/pathology , Vascular Endothelial Growth Factor A/blood
5.
Clin Imaging ; 31(3): 165-77, 2007.
Article in English | MEDLINE | ID: mdl-17449377

ABSTRACT

The aim of this study was to investigate the relationship between 16-slice spiral CT perfusion imaging and tumor angiogenesis and cyclin D1 expression in patients with peripheral lung cancer. Fifty-eight patients with peripheral lung cancer underwent 16-slice spiral CT perfusion imaging. The CT perfusion imaging was analyzed for time density curve (TDC), perfusion parametric maps, and the respective perfusion parameters. Correlation between the respective perfusion parameters and immunohistochemical findings of microvessel density measurement and cyclin D1 expression was evaluated.


Subject(s)
Cyclin D1/biosynthesis , Lung Neoplasms , Neovascularization, Pathologic/diagnostic imaging , Tomography, Spiral Computed/methods , Adenocarcinoma/blood supply , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/metabolism , Adult , Aged , Carcinoma, Large Cell/blood supply , Carcinoma, Large Cell/diagnostic imaging , Carcinoma, Large Cell/metabolism , Carcinoma, Small Cell/blood supply , Carcinoma, Small Cell/diagnostic imaging , Carcinoma, Small Cell/metabolism , Female , Humans , Immunohistochemistry , Lung Neoplasms/blood supply , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/metabolism , Male , Middle Aged
6.
Zhonghua Yi Xue Za Zhi ; 84(23): 1980-2, 2004 Dec 02.
Article in Chinese | MEDLINE | ID: mdl-15730810

ABSTRACT

OBJECTIVE: To investigate the potential of utilizing NY-ESO-1/LAGE-1 antigens in hepatocellular carcinoma (HCC) vaccines. METHODS: RT-PCR method was used to detect the expression of NY-ESO-1/LAGE-1 mRNA in the cancerous tissues and adjacent tissues resected from 34 patients with HCC. ELISA assay was adopted to analyze the NY-ESO-1 specific antibodies in 37 serum samples of HCC patients, 1 positive control sample, and 8 samples of normal persons. RESULTS: Nine (26.5%) out of the 34 HCC samples were NY-ESO-1 mRNA positive, while 12 (35.3%) were LAGE-1 positive. Among them, seven HCC samples expressed both genes, and 14 (41.6%) expressed at least one of the genes. Among the 37 serum samples tested six contained high titer of anti-NY-ESO-1 antibodies. Five of the samples were from stage III or later stage HCC patients; one was from a stage II patient. CONCLUSION: NY-ESO-1/LAGE-1 mRNA is expressed in a high frequency in HCC tissue samples, and induces autologous humoral responses in HCC patients. Both of the antigens can be considered as candidates for HCC vaccines.


Subject(s)
Antibodies, Neoplasm/blood , Antigens, Neoplasm/biosynthesis , Cancer Vaccines/immunology , Carcinoma, Hepatocellular/genetics , Liver Neoplasms/genetics , Membrane Proteins/biosynthesis , Antigens, Neoplasm/genetics , Antigens, Surface , Carcinoma, Hepatocellular/immunology , Humans , Liver Neoplasms/immunology , Male , Membrane Proteins/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Testis
SELECTION OF CITATIONS
SEARCH DETAIL
...